VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q57036352 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010844.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q57036352‏
024 ‎‡a 0000-0002-2470-0795‏ ‎‡2 orcid‏
024 ‎‡a 7102098106‏ ‎‡2 scopus‏
024 ‎‡a 57104456500‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q57036352‏
100 0 ‎‡a Pedro Oliveira‏ ‎‡9 es‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Pedro Oliveira‏ ‎‡c researcher ORCID: 0000-0002-2470-0795‏ ‎‡9 en‏
400 0 ‎‡a P. Oliviera‏ ‎‡9 ga‏
400 0 ‎‡a Pedro Oliveira‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A 10-Year Retrospective Analysis of Methyl Aminolevulinate Photodynamic Therapy Consultation at the Hospital de Braga.‏
670 ‎‡a Author's A twenty-year survey of dermatophytoses in Braga, Portugal.‏
670 ‎‡a Author's Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI.‏
670 ‎‡a Author's An adaptive sharing elitist evolution strategy for multiobjective optimization.‏
670 ‎‡a Author's An epidemiological study determining blood pressure in a Portuguese cohort: the Guimarães/Vizela study‏
670 ‎‡a Author's Arterial stiffness and influences of the metabolic syndrome: a cross-countries study‏
670 ‎‡a Author's Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.‏
670 ‎‡a Author's Association between functional EGF+61 polymorphism and glioma risk.‏
670 ‎‡a Author's Asthma control, quality of life, and the role of patient enablement: a cross-sectional observational study.‏
670 ‎‡a Author's Benchmarking clinical practice in surgery: looking beyond traditional mortality rates.‏
670 ‎‡a Author's Childhood cancer: incidence and spatial patterns in the city of Campinas, Brazil, 1996-2005‏
670 ‎‡a Author's Chronic respiratory patient control by multivariate charts‏
670 ‎‡a Author's Co-selection of the H63D mutation and the HLA-A29 allele: a new paradigm of linkage disequilibrium?‏
670 ‎‡a Author's Comparison between CDC and WHO BMI z-score and their relation with metabolic risk markers in Northern Portuguese obese adolescents‏
670 ‎‡a Author's Dogs mean arterial pressure and heart rate responses during high propofol plasma concentrations estimated by a pharmacokinetic model‏
670 ‎‡a Author's Effectiveness of the association between carbamazepine and peripheral analgesic block with ropivacaine for the treatment of trigeminal neuralgia‏
670 ‎‡a Author's Endovascular Abdominal Aneurysm Repair in Women: What are the Differences Between the Genders?‏
670 ‎‡a Author's Endovascular Treatment of Internal Iliac Artery Aneurysms: Single Center Experience.‏
670 ‎‡a Author's Energy-saving wastewater treatment systems: formulation of cost functions‏
670 ‎‡a Author's Evaluation of fibrosis and inflammation in diffuse liver diseases using intravoxel incoherent motion diffusion-weighted MR imaging‏
670 ‎‡a Author's Evidence for abnormal early development in a mouse model of Rett syndrome.‏
670 ‎‡a Author's Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone‏
670 ‎‡a Author's Identification of GM2-gangliosidosis B1 variant carriers‏
670 ‎‡a Author's Impact of EGFR genetic variants on glioma risk and patient outcome.‏
670 ‎‡a Author's Impact of Endovascular Aortic Aneurysm Repair in a Renal Transplantation Program‏
670 ‎‡a Author's Institutional Impact of EVAR's Incorporation in the Treatment of Abdominal Aortic Aneurysm: a 12 Years' Experience Analysis.‏
670 ‎‡a Author's Intracellular trafficking of AIP56, an NF-κB-cleaving toxin from Photobacterium damselae subsp. piscicida‏
670 ‎‡a Author's Iodine status of pregnant women and their progeny in the Minho Region of Portugal‏
670 ‎‡a Author's Is Age a Determinant Factor in EVAR as a Predictor of Outcomes or in the Selection Procedure? Our Experience‏
670 ‎‡a Author's Leishmania mitochondrial peroxiredoxin plays a crucial peroxidase-unrelated role during infection: insight into its novel chaperone activity‏
670 ‎‡a Author's Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products‏
670 ‎‡a Author's Mutation Frequency of Three Neurodegenerative Lysosomal Storage Diseases: From Screening to Treatment?‏
670 ‎‡a Author's Platelet and leukocyte adhesion to albumin binding self-assembled monolayers‏
670 ‎‡a Author's Psychomotor Development of Children from an Iodine-Deficient Region‏
670 ‎‡a Author's Pulse wave velocity distribution in a cohort study‏
670 ‎‡a Author's Radiation Exposure in Endovascular Infra-Renal Aortic Aneurysm Repair and Factors that Influence It.‏
670 ‎‡a Author's Reduced glucosylceramide in the mouse model of Fabry disease: correction by successful enzyme replacement therapy.‏
670 ‎‡a Author's Risk Factors for Development of Microalbuminuria in Diabetic and Nondiabetic Normoalbuminuric Hypertensives with High or Very High Cardiovascular Risk – A Twelve-Month Follow-Up Study‏
670 ‎‡a Author's Salt intake in children 10-12 years old and its modification by active working practices in a school garden‏
670 ‎‡a Author's Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease‏
670 ‎‡a Author's T Cell Numbers Relate to Bone Involvement in Gaucher Disease‏
670 ‎‡a Author's The apoptogenic toxin AIP56 is a metalloprotease A-B toxin that cleaves NF-κb P65‏
670 ‎‡a Author's The choroid plexus response to peripheral inflammatory stimulus.‏
670 ‎‡a Author's The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer‏
670 ‎‡a Author's The rationale/design of the Guimarães/Vizela study: a multimodal population-based cohort study to determine global cardiovascular risk and disease.‏
670 ‎‡a Author's The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment‏
670 ‎‡a Author's Toxoplasma gondii infection reduces serum progesterone levels and adverse effects at the maternal-foetal interface‏
670 ‎‡a Author's X-linked adrenoleukodystrophy in patients with idiopathic addison disease‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/ISNI|0000000134572304‏
909 ‎‡a (scopus) 57104456500‏ ‎‡9 1‏
909 ‎‡a (scopus) 7102098106‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000224700795‏ ‎‡9 1‏
919 ‎‡a impactofegfrgeneticvariantsongliomariskandpatientoutcome‏ ‎‡A Impact of EGFR genetic variants on glioma risk and patient outcome.‏ ‎‡9 1‏
919 ‎‡a gabapentinsupplementedwithropivacainblockoftriggerpointsimprovespaincontrolandqualityoflifeintrigeminalneuralgiapatientswhencomparedwithgabapentinalone‏ ‎‡A Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone‏ ‎‡9 1‏
919 ‎‡a evidenceforabnormalearlydevelopmentinamousemodelofrettsyndrome‏ ‎‡A Evidence for abnormal early development in a mouse model of Rett syndrome.‏ ‎‡9 1‏
919 ‎‡a reducedglucosylceramideinthemousemodeloffabrydiseasecorrectionbysuccessfulenzymereplacementtherapy‏ ‎‡A Reduced glucosylceramide in the mouse model of Fabry disease: correction by successful enzyme replacement therapy.‏ ‎‡9 1‏
919 ‎‡a riskfactorsfordevelopmentofmicroalbuminuriaindiabeticandnondiabeticnormoalbuminurichypertensiveswithhighorveryhighcardiovascularriska12monthfollowupstudy‏ ‎‡A Risk Factors for Development of Microalbuminuria in Diabetic and Nondiabetic Normoalbuminuric Hypertensives with High or Very High Cardiovascular Risk – A Twelve-Month Follow-Up Study‏ ‎‡9 1‏
919 ‎‡a evaluationoffibrosisandinflammationindiffuseliverdiseasesusingintravoxelincoherentmotiondiffusionweightedmrimaging‏ ‎‡A Evaluation of fibrosis and inflammation in diffuse liver diseases using intravoxel incoherent motion diffusion-weighted MR imaging‏ ‎‡9 1‏
919 ‎‡a energysavingwastewatertreatmentsystemsformulationofcostfunctions‏ ‎‡A Energy-saving wastewater treatment systems: formulation of cost functions‏ ‎‡9 1‏
919 ‎‡a endovasculartreatmentofinternaliliacarteryaneurysmssinglecenterexperience‏ ‎‡A Endovascular Treatment of Internal Iliac Artery Aneurysms: Single Center Experience.‏ ‎‡9 1‏
919 ‎‡a endovascularabdominalaneurysmrepairinwomenwhatarethedifferencesbetweenthegenders‏ ‎‡A Endovascular Abdominal Aneurysm Repair in Women: What are the Differences Between the Genders?‏ ‎‡9 1‏
919 ‎‡a effectivenessoftheassociationbetweencarbamazepineandperipheralanalgesicblockwithropivacaineforthetreatmentoftrigeminalneuralgia‏ ‎‡A Effectiveness of the association between carbamazepine and peripheral analgesic block with ropivacaine for the treatment of trigeminal neuralgia‏ ‎‡9 1‏
919 ‎‡a dogsmeanarterialpressureandheartrateresponsesduringhighpropofolplasmaconcentrationsestimatedbyapharmacokineticmodel‏ ‎‡A Dogs mean arterial pressure and heart rate responses during high propofol plasma concentrations estimated by a pharmacokinetic model‏ ‎‡9 1‏
919 ‎‡a saltintakeinchildren1012yearsoldanditsmodificationbyactiveworkingpracticesinaschoolgarden‏ ‎‡A Salt intake in children 10-12 years old and its modification by active working practices in a school garden‏ ‎‡9 1‏
919 ‎‡a comparisonbetweencdcandwhobmizscoreandtheirrelationwithmetabolicriskmarkersinnorthernportugueseobeseadolescents‏ ‎‡A Comparison between CDC and WHO BMI z-score and their relation with metabolic risk markers in Northern Portuguese obese adolescents‏ ‎‡9 1‏
919 ‎‡a tcellnumbersrelatetoboneinvolvementingaucherdisease‏ ‎‡A T Cell Numbers Relate to Bone Involvement in Gaucher Disease‏ ‎‡9 1‏
919 ‎‡a coselectionoftheh63dmutationandthehlaa29alleleanewparadigmoflinkagedisequilibrium‏ ‎‡A Co-selection of the H63D mutation and the HLA-A29 allele: a new paradigm of linkage disequilibrium?‏ ‎‡9 1‏
919 ‎‡a chronicrespiratorypatientcontrolbymultivariatecharts‏ ‎‡A Chronic respiratory patient control by multivariate charts‏ ‎‡9 1‏
919 ‎‡a childhoodcancerincidenceandspatialpatternsinthecityofcampinasbrazil1996‏ ‎‡A Childhood cancer: incidence and spatial patterns in the city of Campinas, Brazil, 1996-2005‏ ‎‡9 1‏
919 ‎‡a choroidplexusresponsetoperipheralinflammatorystimulus‏ ‎‡A The choroid plexus response to peripheral inflammatory stimulus.‏ ‎‡9 1‏
919 ‎‡a impactofpolymorphicvariationsinthe5p156p126p21and15q25lociontheriskandprognosisofportuguesepatientswithnonsmallcelllungcancer‏ ‎‡A The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer‏ ‎‡9 1‏
919 ‎‡a benchmarkingclinicalpracticeinsurgerylookingbeyondtraditionalmortalityrates‏ ‎‡A Benchmarking clinical practice in surgery: looking beyond traditional mortality rates.‏ ‎‡9 1‏
919 ‎‡a asthmacontrolqualityoflifeandtheroleofpatientenablementacrosssectionalobservationalstudy‏ ‎‡A Asthma control, quality of life, and the role of patient enablement: a cross-sectional observational study.‏ ‎‡9 1‏
919 ‎‡a rationaledesignoftheguimaraesvizelastudyamultimodalpopulationbasedcohortstudytodetermineglobalcardiovascularriskanddisease‏ ‎‡A The rationale/design of the Guimarães/Vizela study: a multimodal population-based cohort study to determine global cardiovascular risk and disease.‏ ‎‡9 1‏
919 ‎‡a associationbetweenfunctionalegf+61polymorphismandgliomarisk‏ ‎‡A Association between functional EGF+61 polymorphism and glioma risk.‏ ‎‡9 1‏
919 ‎‡a selectivecox2inhibitoretoricoxibreducesacuteinflammatorymarkersinamodelofneurogeniclaryngitisbutlosesitsefficacywithprolongedtreatment‏ ‎‡A The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment‏ ‎‡9 1‏
919 ‎‡a associationbetweenegf+61geneticpolymorphismsandnonsmallcelllungcancerincreasedriskinaportuguesepopulationacasecontrolstudy‏ ‎‡A Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.‏ ‎‡9 1‏
919 ‎‡a arterialstiffnessandinfluencesofthemetabolicsyndromeacrosscountriesstudy‏ ‎‡A Arterial stiffness and influences of the metabolic syndrome: a cross-countries study‏ ‎‡9 1‏
919 ‎‡a epidemiologicalstudydeterminingbloodpressureinaportuguesecohorttheguimaraesvizelastudy‏ ‎‡A An epidemiological study determining blood pressure in a Portuguese cohort: the Guimarães/Vizela study‏ ‎‡9 1‏
919 ‎‡a adaptivesharingelitistevolutionstrategyformultiobjectiveoptimization‏ ‎‡A An adaptive sharing elitist evolution strategy for multiobjective optimization.‏ ‎‡9 1‏
919 ‎‡a toxoplasmagondiiinfectionreducesserumprogesteronelevelsandadverseeffectsatthematernalfoetalinterface‏ ‎‡A Toxoplasma gondii infection reduces serum progesterone levels and adverse effects at the maternal-foetal interface‏ ‎‡9 1‏
919 ‎‡a 10linkedadrenoleukodystrophyinpatientswithidiopathicaddisondisease‏ ‎‡A X-linked adrenoleukodystrophy in patients with idiopathic addison disease‏ ‎‡9 1‏
919 ‎‡a accuratesimultaneousquantificationofliversteatosisandironoverloadindiffuseliverdiseaseswithmri‏ ‎‡A Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI.‏ ‎‡9 1‏
919 ‎‡a 20yearsurveyofdermatophytosesinbragaportugal‏ ‎‡A A twenty-year survey of dermatophytoses in Braga, Portugal.‏ ‎‡9 1‏
919 ‎‡a 10yearretrospectiveanalysisofmethylaminolevulinatephotodynamictherapyconsultationatthehospitaldebraga‏ ‎‡A A 10-Year Retrospective Analysis of Methyl Aminolevulinate Photodynamic Therapy Consultation at the Hospital de Braga.‏ ‎‡9 1‏
919 ‎‡a serotonergicsignallingsuppressesataxin3aggregationandneurotoxicityinanimalmodelsofmachadojosephdisease‏ ‎‡A Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease‏ ‎‡9 1‏
919 ‎‡a identificationofgm2gangliosidosisb1variantcarriers‏ ‎‡A Identification of GM2-gangliosidosis B1 variant carriers‏ ‎‡9 1‏
919 ‎‡a plateletandleukocyteadhesiontoalbuminbindingselfassembledmonolayers‏ ‎‡A Platelet and leukocyte adhesion to albumin binding self-assembled monolayers‏ ‎‡9 1‏
919 ‎‡a iodinestatusofpregnantwomenandtheirprogenyintheminhoregionofportugal‏ ‎‡A Iodine status of pregnant women and their progeny in the Minho Region of Portugal‏ ‎‡9 1‏
919 ‎‡a apoptogenictoxinaip56isametalloproteaseabtoxinthatcleavesnfκbp65‏ ‎‡A The apoptogenic toxin AIP56 is a metalloprotease A-B toxin that cleaves NF-κb P65‏ ‎‡9 1‏
919 ‎‡a psychomotordevelopmentofchildrenfromaniodinedeficientregion‏ ‎‡A Psychomotor Development of Children from an Iodine-Deficient Region‏ ‎‡9 1‏
919 ‎‡a mutationfrequencyof3neurodegenerativelysosomalstoragediseasesfromscreeningtotreatment‏ ‎‡A Mutation Frequency of Three Neurodegenerative Lysosomal Storage Diseases: From Screening to Treatment?‏ ‎‡9 1‏
919 ‎‡a motoruncoordinationandneuropathologyinatransgenicmousemodelofmachadojosephdiseaselackingintranuclearinclusionsandataxin3cleavageproducts‏ ‎‡A Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products‏ ‎‡9 1‏
919 ‎‡a pulsewavevelocitydistributioninacohortstudy‏ ‎‡A Pulse wave velocity distribution in a cohort study‏ ‎‡9 1‏
919 ‎‡a leishmaniamitochondrialperoxiredoxinplaysacrucialperoxidaseunrelatedroleduringinfectioninsightintoitsnovelchaperoneactivity‏ ‎‡A Leishmania mitochondrial peroxiredoxin plays a crucial peroxidase-unrelated role during infection: insight into its novel chaperone activity‏ ‎‡9 1‏
919 ‎‡a institutionalimpactofevarsincorporationinthetreatmentofabdominalaorticaneurysma12yearsexperienceanalysis‏ ‎‡A Institutional Impact of EVAR's Incorporation in the Treatment of Abdominal Aortic Aneurysm: a 12 Years' Experience Analysis.‏ ‎‡9 1‏
919 ‎‡a intracellulartraffickingofaip56annfκbcleavingtoxinfromphotobacteriumdamselaesubsppiscicida‏ ‎‡A Intracellular trafficking of AIP56, an NF-κB-cleaving toxin from Photobacterium damselae subsp. piscicida‏ ‎‡9 1‏
919 ‎‡a isageadeterminantfactorinevarasapredictorofoutcomesorintheselectionprocedureourexperience‏ ‎‡A Is Age a Determinant Factor in EVAR as a Predictor of Outcomes or in the Selection Procedure? Our Experience‏ ‎‡9 1‏
919 ‎‡a radiationexposureinendovascularinfrarenalaorticaneurysmrepairandfactorsthatinfluenceit‏ ‎‡A Radiation Exposure in Endovascular Infra-Renal Aortic Aneurysm Repair and Factors that Influence It.‏ ‎‡9 1‏
919 ‎‡a impactofendovascularaorticaneurysmrepairinarenaltransplantationprogram‏ ‎‡A Impact of Endovascular Aortic Aneurysm Repair in a Renal Transplantation Program‏ ‎‡9 1‏
943 ‎‡a 200x‏ ‎‡A 2005‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 BLBNB|001476984‏
996 ‎‡2 CAOONL|ncf11895867‏
996 ‎‡2 SUDOC|254411096‏
996 ‎‡2 LC|no2021041425‏
996 ‎‡2 PTBNP|167766‏
996 ‎‡2 DNB|1052650694‏
996 ‎‡2 ISNI|0000000068111752‏
996 ‎‡2 BIBSYS|15018697‏
996 ‎‡2 PTBNP|1827892‏
996 ‎‡2 SUDOC|092223206‏
996 ‎‡2 ISNI|0000000069387435‏
996 ‎‡2 PTBNP|788453‏
996 ‎‡2 BLBNB|000513471‏
996 ‎‡2 BLBNB|001558919‏
996 ‎‡2 BLBNB|000541247‏
996 ‎‡2 ISNI|0000000068398562‏
996 ‎‡2 BLBNB|001590955‏
996 ‎‡2 DNB|1302586661‏
996 ‎‡2 BLBNB|000992943‏
996 ‎‡2 PTBNP|1456246‏
996 ‎‡2 DNB|1172313482‏
996 ‎‡2 ISNI|0000000051171409‏
996 ‎‡2 PTBNP|1917072‏
996 ‎‡2 BNC|981058589163006706‏
996 ‎‡2 DNB|14001196X‏
996 ‎‡2 PTBNP|1564806‏
996 ‎‡2 BLBNB|000493227‏
996 ‎‡2 DNB|1247759520‏
996 ‎‡2 DNB|1259821722‏
996 ‎‡2 PTBNP|1240271‏
996 ‎‡2 BLBNB|000369849‏
996 ‎‡2 PTBNP|1147117‏
996 ‎‡2 NUKAT|n 2021203886‏
996 ‎‡2 LC|nb2014018519‏
996 ‎‡2 ISNI|0000000068595451‏
996 ‎‡2 BLBNB|000430141‏
996 ‎‡2 ISNI|0000000070984405‏
996 ‎‡2 BLBNB|001014104‏
996 ‎‡2 SUDOC|230099769‏
996 ‎‡2 DNB|1177402823‏
996 ‎‡2 NKC|jx20091008005‏
996 ‎‡2 PTBNP|1918241‏
996 ‎‡2 SUDOC|170745686‏
996 ‎‡2 PLWABN|9813654879005606‏
996 ‎‡2 BLBNB|000271387‏
996 ‎‡2 PTBNP|1506370‏
996 ‎‡2 DNB|122789676X‏
996 ‎‡2 BLBNB|001509921‏
996 ‎‡2 LC|no2010022267‏
996 ‎‡2 DNB|1325745391‏
996 ‎‡2 BLBNB|000247338‏
996 ‎‡2 BLBNB|001561193‏
996 ‎‡2 ISNI|0000000078864993‏
996 ‎‡2 PTBNP|1239072‏
996 ‎‡2 LC|nb2019020237‏
996 ‎‡2 DNB|133079562‏
996 ‎‡2 BLBNB|001134244‏
996 ‎‡2 BLBNB|000510063‏
996 ‎‡2 ISNI|0000000069905941‏
996 ‎‡2 LC|nr2005010749‏
996 ‎‡2 LC|n 93900609‏
996 ‎‡2 LC|n 2007067376‏
996 ‎‡2 LC|no2011014252‏
996 ‎‡2 PTBNP|1215480‏
996 ‎‡2 PTBNP|151737‏
996 ‎‡2 ISNI|0000000036974393‏
996 ‎‡2 ISNI|000000006961866X‏
996 ‎‡2 LC|no2001056671‏
996 ‎‡2 PTBNP|1293072‏
996 ‎‡2 PTBNP|1176828‏
996 ‎‡2 LC|no2012062173‏
996 ‎‡2 PTBNP|176363‏
996 ‎‡2 SZ|1189153696‏
996 ‎‡2 DNB|1189153696‏
996 ‎‡2 DNB|1257933582‏
996 ‎‡2 BLBNB|001461510‏
996 ‎‡2 DNB|1022103083‏
996 ‎‡2 PTBNP|1746590‏
996 ‎‡2 RERO|A026624254‏
996 ‎‡2 SZ|108125369X‏
996 ‎‡2 ISNI|0000000097157784‏
996 ‎‡2 BLBNB|001578222‏
996 ‎‡2 PTBNP|1537422‏
996 ‎‡2 DNB|1215864302‏
996 ‎‡2 BLBNB|000583815‏
996 ‎‡2 PTBNP|1358998‏
996 ‎‡2 LC|n 2013201331‏
996 ‎‡2 ISNI|0000000112391270‏
996 ‎‡2 LC|no2022152406‏
996 ‎‡2 BIBSYS|12033660‏
996 ‎‡2 ISNI|000000042665837X‏
996 ‎‡2 ISNI|000000006881399X‏
996 ‎‡2 BLBNB|001573541‏
996 ‎‡2 SUDOC|076098311‏
996 ‎‡2 ISNI|0000000070995876‏
996 ‎‡2 LC|no 98085748‏
996 ‎‡2 ISNI|000000007000450X‏
996 ‎‡2 J9U|987007323295705171‏
996 ‎‡2 PTBNP|1452289‏
996 ‎‡2 ISNI|0000000428264198‏
996 ‎‡2 PTBNP|1688173‏
996 ‎‡2 BLBNB|000443009‏
996 ‎‡2 ISNI|0000000070096336‏
996 ‎‡2 PTBNP|1455337‏
996 ‎‡2 BLBNB|001501549‏
996 ‎‡2 DNB|1056621656‏
996 ‎‡2 SUDOC|070204322‏
996 ‎‡2 LC|n 2023253852‏
996 ‎‡2 PTBNP|1352660‏
996 ‎‡2 PTBNP|966686‏
996 ‎‡2 NTA|073718483‏
996 ‎‡2 ISNI|0000000474745523‏
996 ‎‡2 PTBNP|1406718‏
996 ‎‡2 ISNI|0000000070415958‏
996 ‎‡2 ISNI|0000000084960121‏
996 ‎‡2 LC|no2007046789‏
996 ‎‡2 DNB|105893838X‏
996 ‎‡2 SUDOC|225425777‏
996 ‎‡2 PTBNP|1887613‏
996 ‎‡2 NTA|403930146‏
996 ‎‡2 ISNI|000000008766300X‏
996 ‎‡2 BLBNB|000590218‏
996 ‎‡2 PTBNP|1554241‏
996 ‎‡2 LC|no 99062997‏
996 ‎‡2 BLBNB|000312326‏
996 ‎‡2 PTBNP|1607564‏
996 ‎‡2 LC|no2008011148‏
996 ‎‡2 SUDOC|078698197‏
996 ‎‡2 BLBNB|000312328‏
996 ‎‡2 BLBNB|001512083‏
996 ‎‡2 SUDOC|145725812‏
996 ‎‡2 ISNI|0000000389803733‏
996 ‎‡2 NUKAT|n 2016181255‏
996 ‎‡2 DNB|1208642243‏
996 ‎‡2 ISNI|000000043037816X‏
996 ‎‡2 PTBNP|1292970‏
996 ‎‡2 LC|n 2023037493‏
996 ‎‡2 LC|n 2015070504‏
996 ‎‡2 ISNI|000000008441637X‏
996 ‎‡2 LC|n 97007858‏
996 ‎‡2 ISNI|0000000111753794‏
996 ‎‡2 ISNI|0000000428225236‏
996 ‎‡2 SUDOC|264825047‏
996 ‎‡2 PTBNP|1537807‏
996 ‎‡2 BLBNB|000498364‏
996 ‎‡2 PTBNP|1414928‏
996 ‎‡2 LC|nb2013013518‏
996 ‎‡2 SUDOC|230452345‏
996 ‎‡2 LC|n 2014205253‏
996 ‎‡2 DNB|170072916‏
996 ‎‡2 NUKAT|n 2007141370‏
996 ‎‡2 LC|n 2018181346‏
996 ‎‡2 PTBNP|1473038‏
996 ‎‡2 PTBNP|1473501‏
996 ‎‡2 PTBNP|1445252‏
996 ‎‡2 DNB|170993140‏
996 ‎‡2 ISNI|0000000428220611‏
996 ‎‡2 PTBNP|33971‏
996 ‎‡2 PTBNP|1152948‏
996 ‎‡2 PTBNP|1772453‏
996 ‎‡2 NUKAT|n 2019160238‏
996 ‎‡2 BAV|495_241339‏
996 ‎‡2 PTBNP|1451971‏
996 ‎‡2 PTBNP|1423994‏
996 ‎‡2 BLBNB|000223233‏
996 ‎‡2 DNB|1334523975‏
996 ‎‡2 ISNI|0000000070228730‏
996 ‎‡2 BLBNB|000496204‏
996 ‎‡2 BLBNB|000498587‏
996 ‎‡2 BLBNB|000372397‏
996 ‎‡2 DNB|1034537148‏
996 ‎‡2 PTBNP|1438738‏
996 ‎‡2 BNE|XX4432926‏
996 ‎‡2 ISNI|0000000034589483‏
996 ‎‡2 ISNI|0000000069185227‏
996 ‎‡2 PTBNP|254928‏
996 ‎‡2 ISNI|0000000453649487‏
996 ‎‡2 PTBNP|1816377‏
996 ‎‡2 PTBNP|1282360‏
996 ‎‡2 DNB|174021992‏
996 ‎‡2 PTBNP|1452791‏
996 ‎‡2 BLBNB|001479147‏
996 ‎‡2 ISNI|0000000357730525‏
996 ‎‡2 BNF|17088377‏
996 ‎‡2 ISNI|0000000370614377‏
996 ‎‡2 PTBNP|1768004‏
996 ‎‡2 DNB|108125369X‏
996 ‎‡2 BLBNB|001588547‏
996 ‎‡2 LC|no 97046775‏
996 ‎‡2 SUDOC|255276508‏
996 ‎‡2 PTBNP|1855659‏
996 ‎‡2 BLBNB|000273950‏
996 ‎‡2 LC|n 85080454‏
996 ‎‡2 NUKAT|n 2011011539‏
996 ‎‡2 PTBNP|1416689‏
996 ‎‡2 PTBNP|1425738‏
996 ‎‡2 ISNI|0000000070899016‏
996 ‎‡2 LC|n 2024250352‏
996 ‎‡2 ISNI|0000000428130667‏
996 ‎‡2 ISNI|0000000068217178‏
996 ‎‡2 NSK|000628844‏
996 ‎‡2 PTBNP|28416‏
996 ‎‡2 ISNI|0000000027775923‏
996 ‎‡2 LC|n 2023251898‏
996 ‎‡2 PTBNP|1910144‏
996 ‎‡2 SZ|1128764660‏
996 ‎‡2 PTBNP|1204186‏
996 ‎‡2 PTBNP|273072‏
996 ‎‡2 ISNI|0000000113900233‏
996 ‎‡2 SUDOC|253551277‏
996 ‎‡2 BLBNB|001114359‏
996 ‎‡2 ISNI|0000000052086230‏
996 ‎‡2 LC|n 00034316‏
996 ‎‡2 BLBNB|000679394‏
996 ‎‡2 PTBNP|343372‏
996 ‎‡2 PLWABN|9810622035205606‏
996 ‎‡2 NUKAT|n 2022002247‏
996 ‎‡2 ISNI|0000000078144769‏
996 ‎‡2 LC|n 99909523‏
996 ‎‡2 ISNI|0000000108153800‏
996 ‎‡2 ISNI|0000000434878436‏
996 ‎‡2 LC|n 2024181242‏
996 ‎‡2 ISNI|0000000069906231‏
996 ‎‡2 SUDOC|083705082‏
996 ‎‡2 ISNI|000000007814147X‏
996 ‎‡2 PTBNP|60186‏
996 ‎‡2 PTBNP|1436866‏
996 ‎‡2 LC|no2020008075‏
996 ‎‡2 PTBNP|1422764‏
996 ‎‡2 DNB|139726322‏
996 ‎‡2 ISNI|0000000079697058‏
996 ‎‡2 PTBNP|1378011‏
996 ‎‡2 BNF|14647545‏
996 ‎‡2 ISNI|0000000428306490‏
996 ‎‡2 BLBNB|001545658‏
996 ‎‡2 LC|n 2018181477‏
996 ‎‡2 BLBNB|000522194‏
996 ‎‡2 DNB|112269282X‏
996 ‎‡2 DNB|1057356972‏
996 ‎‡2 PTBNP|1771177‏
996 ‎‡2 ISNI|0000000068883947‏
996 ‎‡2 DNB|1053035993‏
996 ‎‡2 DNB|1044491531‏
996 ‎‡2 LC|n 82108516‏
996 ‎‡2 LC|n 2001130199‏
996 ‎‡2 PTBNP|184413‏
996 ‎‡2 SUDOC|150800444‏
996 ‎‡2 ISNI|0000000067449372‏
996 ‎‡2 ISNI|0000000055011269‏
996 ‎‡2 DNB|1315239817‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏
998 ‎‡a Oliveira, Pedro‏ ‎‡2 PLWABN|9810668447705606‏ ‎‡3 viafid‏ ‎‡3 title: (0.74, 'controlchartsandchronicrespiratorypatients', 'chronicrespiratorypatientcontrolbymultivariatecharts')‏